Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Sell
8,418
-2,680
-24% -$917K 0.29% 46
2026
Q1
$3.9M Sell
11,098
-234
-2% -$83.4K 0.43% 43
2025
Q4
$3.71M Sell
11,332
-594
-5% -$188K 0.38% 45
2025
Q3
$3.37M Sell
11,926
-154
-1% -$44.7K 0.35% 47
2025
Q2
$3.37M Buy
12,080
+465
+4% +$132K 0.38% 45
2025
Q1
$3.62M Sell
11,615
-11
-0.1% -$3.25K 0.46% 41
2024
Q4
$3.03M Buy
11,626
+166
+1% +$49.3K 0.38% 43
2024
Q3
$3.69M Buy
11,460
+297
+3% +$97.2K 0.45% 46
2024
Q2
$3.49M Buy
11,163
+391
+4% +$115K 0.44% 47
2024
Q1
$3.06M Buy
10,772
+815
+8% +$238K 0.38% 47
2023
Q4
$2.87M Buy
9,957
+1,533
+18% +$418K 0.4% 48
2023
Q3
$2.26M Buy
8,424
+2,485
+42% +$620K 0.35% 49
2023
Q2
$1.32M Buy
5,939
+2,841
+92% +$659K 0.19% 50
2023
Q1
$749K Buy
3,098
+2,158
+230% +$530K 0.11% 63
2022
Q4
$247K Sell
940
-25
-3% -$6.7K 0.04% 88
2022
Q3
$218K Buy
+965
New +$234K 0.04% 85
2021
Q3
Sell
-1,088
Closed -$265K 101
2021
Q2
$265K Hold
1,088
0.04% 79
2021
Q1
$271K Sell
1,088
-34
-3% -$8.11K 0.04% 80
2020
Q4
$258K Buy
1,122
+45
+4% +$10.4K 0.04% 97
2020
Q3
$274K Sell
1,077
-55
-5% -$13.6K 0.05% 83
2020
Q2
$267K Buy
1,132
+6
+0.5% +$1.37K 0.05% 81
2020
Q1
$228K Sell
1,126
-919
-45% -$201K 0.05% 83
2019
Q4
$493K Buy
2,045
+175
+9% +$38.6K 0.07% 79
2019
Q3
$362K Sell
1,870
-102
-5% -$19.6K 0.05% 84
2019
Q2
$363K Sell
1,972
-1,115
-36% -$200K 0.05% 85
2019
Q1
$586K Sell
3,087
-55,931
-95% -$10.7M 0.09% 69
2018
Q4
$11.5M Buy
59,018
+2,505
+4% +$489K 2.1% 18
2018
Q3
$11.7M Buy
56,513
+3,672
+7% +$724K 1.67% 24
2018
Q2
$9.75M Buy
52,841
+802
+2% +$142K 1.52% 29
2018
Q1
$8.87M Buy
52,039
+4,343
+9% +$797K 1.41% 31
2017
Q4
$8.29M Buy
47,696
+3,299
+7% +$584K 1.4% 29
2017
Q3
$8.28M Buy
44,397
+1,086
+3% +$192K 1.47% 29
2017
Q2
$7.46M Buy
43,311
+1,869
+5% +$304K 1.41% 30
2017
Q1
$6.8M Buy
41,442
+3,181
+8% +$529K 1.35% 33
2016
Q4
$5.85M Buy
38,261
+3,774
+11% +$568K 1.23% 36
2016
Q3
$5.75M Buy
34,487
+443
+1% +$74.9K 1.31% 36
2016
Q2
$5.45M Buy
34,044
+2,908
+9% +$452K 1.27% 38
2016
Q1
$4.67M Buy
31,136
+25,271
+431% +$3.75M 1.17% 39
2015
Q4
$952K Buy
5,865
+85
+1% +$13.4K 0.49% 51
2015
Q3
$856K Buy
5,780
+280
+5% +$44.1K 0.46% 49
2015
Q2
$832K Buy
5,500
+235
+4% +$37.6K 0.42% 53
2015
Q1
$842K Sell
5,265
-65
-1% -$10.2K 0.43% 54
2014
Q4
$849K Sell
5,330
-12,141
-69% -$1.89M 0.43% 49
2014
Q3
$2.45M Sell
17,471
-575
-3% -$75.1K 0.72% 51
2014
Q2
$2.14M Buy
18,046
+3,185
+21% +$369K 0.64% 51
2014
Q1
$1.83M Hold
14,861
0.59% 51
2013
Q4
$1.69M Buy
14,861
+10,816
+267% +$1.23M 0.6% 50
2013
Q3
$453K Sell
4,045
-9,205
-69% -$998K 0.3% 67
2013
Q2
$1.31M Buy
+13,250
New +$1.37M 0.55% 56

Other funds holding AMGN

Abner Herrman & Brock's AMGN Position: Q2 2026 in Review

Abner Herrman & Brock reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $917K and leaving 8,418 shares worth $3.05M. The position accounts for 0.29% of the portfolio, ranked #46.

Abner Herrman & Brock first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $11.7M in Q3 2018. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Abner Herrman & Brock held 8,418 shares of Amgen worth $3.05M as of Q2 2026.
  • Abner Herrman & Brock sold 2,680 Amgen shares in Q2 2026, an estimated $917K.
  • Amgen made up 0.29% of Abner Herrman & Brock's portfolio in Q2 2026, its #46 holding.
  • Abner Herrman & Brock first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
  • Abner Herrman & Brock's Amgen position peaked at $11.7M in Q3 2018.
  • 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.